Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Q Huang

Showing results (91-100 of 221) with videos related to

Pageof 23
Sort By:
Alimentary Pharmacology & Therapeutics|April 4, 2024
Natural history of clinical outcomes and hepatic decompensation in metabolic dysfunction-associated steatotic liver diseaseNabil Noureddin, Daniel Q Huang, Ricki Bettencourt, et al.
Digestive Diseases and Sciences|May 16, 2026
Racial Disparities in Clinical and Cardiometabolic Outcomes Among Patients with Alcohol-Associated Liver DiseasePradhan Hariharan, Majd B Aboona, Janet Foote, et al.
The Lancet Regional Health. Western Pacific|September 13, 2021
Impact of COVID-19 on Liver Transplantation in Hong Kong and Singapore: A Modelling StudyEunice Xiang-Xuan Tan, Wei Liang Quek, Suryadi, et al.
Alimentary Pharmacology & Therapeutics|June 3, 2023
Clinical and histologic factors associated with discordance between steatosis grade derived from histology vs. MRI-PDFF in NAFLDBeom K Kim, Nicole Bernstein, Daniel Q Huang, et al.
Journal of Gastroenterology and Hepatology|April 27, 2025
Head-to-Head Comparison of Long-Term HCC Risk of Antivirals-Treated Versus Untreated Low-Level Viremia in HBV-Compensated CirrhosisNobuharu Tamaki, Daniel Q Huang, Hyung Woong Lee, et al.
Cellular and Molecular Gastroenterology and Hepatology|December 19, 2020
Predicting HCC Response to Multikinase Inhibitors With In Vivo Cirrhotic Mouse Model for Personalized TherapyDaniel Q Huang, Mark D Muthiah, Lei Zhou, et al.
Cancers|September 13, 2025
Contemporary Changes in Global Trends in Early-Onset Cancer: Incidence and Mortality (2000-2021)Pojsakorn Danpanichkul, Yanfang Pang, Supapitch Sirimangklanurak, et al.
Alimentary Pharmacology & Therapeutics|June 28, 2025
Meta-Analysis: Effects of Steatotic Liver Disease-Associated Genetic Risk Alleles on Longitudinal OutcomesMatthew Kubina, Vitchapong Prasitsumrit, Jarell Tan, et al.
Clinical and Molecular Hepatology|April 11, 2025
Sex Disparities in Alcohol-Associated Liver Disease and Subtype Differences in Alcohol-attributable Cancers in the United StatesPojsakorn Danpanichkul, Yanfang Pang, Tanuj Mahendru, et al.
Mayo Clinic Proceedings|March 29, 2024
Metabolic Syndrome and Metabolic Dysfunction-Associated Steatotic Liver Disease in Premenopausal Women: Global Trends and Projections to 2040Pojsakorn Danpanichkul, Cheng Han Ng, Mark D Muthiah, et al.
Pageof 23

Showing results (91-100 of 221) with videos related to

Sort By:
Pageof 23
Alimentary Pharmacology & Therapeutics|April 4, 2024
Natural history of clinical outcomes and hepatic decompensation in metabolic dysfunction-associated steatotic liver diseaseNabil Noureddin, Daniel Q Huang, Ricki Bettencourt, et al.
Digestive Diseases and Sciences|May 16, 2026
Racial Disparities in Clinical and Cardiometabolic Outcomes Among Patients with Alcohol-Associated Liver DiseasePradhan Hariharan, Majd B Aboona, Janet Foote, et al.
The Lancet Regional Health. Western Pacific|September 13, 2021
Impact of COVID-19 on Liver Transplantation in Hong Kong and Singapore: A Modelling StudyEunice Xiang-Xuan Tan, Wei Liang Quek, Suryadi, et al.
Alimentary Pharmacology & Therapeutics|June 3, 2023
Clinical and histologic factors associated with discordance between steatosis grade derived from histology vs. MRI-PDFF in NAFLDBeom K Kim, Nicole Bernstein, Daniel Q Huang, et al.
Journal of Gastroenterology and Hepatology|April 27, 2025
Head-to-Head Comparison of Long-Term HCC Risk of Antivirals-Treated Versus Untreated Low-Level Viremia in HBV-Compensated CirrhosisNobuharu Tamaki, Daniel Q Huang, Hyung Woong Lee, et al.
Cellular and Molecular Gastroenterology and Hepatology|December 19, 2020
Predicting HCC Response to Multikinase Inhibitors With In Vivo Cirrhotic Mouse Model for Personalized TherapyDaniel Q Huang, Mark D Muthiah, Lei Zhou, et al.
Cancers|September 13, 2025
Contemporary Changes in Global Trends in Early-Onset Cancer: Incidence and Mortality (2000-2021)Pojsakorn Danpanichkul, Yanfang Pang, Supapitch Sirimangklanurak, et al.
Alimentary Pharmacology & Therapeutics|June 28, 2025
Meta-Analysis: Effects of Steatotic Liver Disease-Associated Genetic Risk Alleles on Longitudinal OutcomesMatthew Kubina, Vitchapong Prasitsumrit, Jarell Tan, et al.
Clinical and Molecular Hepatology|April 11, 2025
Sex Disparities in Alcohol-Associated Liver Disease and Subtype Differences in Alcohol-attributable Cancers in the United StatesPojsakorn Danpanichkul, Yanfang Pang, Tanuj Mahendru, et al.
Mayo Clinic Proceedings|March 29, 2024
Metabolic Syndrome and Metabolic Dysfunction-Associated Steatotic Liver Disease in Premenopausal Women: Global Trends and Projections to 2040Pojsakorn Danpanichkul, Cheng Han Ng, Mark D Muthiah, et al.
Pageof 23